NVS logo

Novartis AG (NVS) Long term debt

Annual long term debt:

$22.93B+$2.90B(+14.48%)
December 31, 2024

Summary

  • As of today (May 21, 2025), NVS annual long term debt is $22.93 billion, with the most recent change of +$2.90 billion (+14.48%) on December 31, 2024.
  • During the last 3 years, NVS annual long term debt has fallen by -$1.59 billion (-6.48%).
  • NVS annual long term debt is now -18.03% below its all-time high of $27.98 billion, reached on December 31, 2020.

Performance

1-year change

+14.48%

3-year change

-6.48%

5-year change

+3.98%

15-year change

-1.25%

NVS Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.36%
NVS annual long term debt is higher than 98.36% of companies in Healthcare sector

Range

All-time high

$27.98B
NVS annual long term debt is currently -18.03% below its historical high of $27.98 billion

3-year low

$20.03B
NVS annual long term debt is currently +14.48% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
NVS previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
NVS next annual earnings announcement has not yet been scheduled

OtherNVSbalance sheet metrics

Annual Total Debt

$31.26B
NVS annual total debt is $31.26 billion

Annual short term debt

$8.32B
NVS annual short term debt is $8.32 billion

annual total liabilities

$58.12B
NVS annual total liabilities is $58.12 billion

annual total assets

$102.25B
NVS annual total assets is $102.25 billion

Quarterly long term debt:

$23.23B+$293.00M(+1.28%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVS quarterly long term debt is $23.23 billion, with the most recent change of +$293.00 million (+1.28%) on March 31, 2025.
  • Over the past year, NVS quarterly long term debt has increased by +$4.51 billion (+24.08%).
  • NVS quarterly long term debt is now -17.58% below its all-time high of $28.18 billion, reached on September 30, 2020.

Performance

3-month change

+1.28%

1-year change

+24.08%

3-year change

-4.7%

5-year change

-8.88%

NVS Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.39%
NVS quarterly long term debt is higher than 98.39% of companies in Healthcare sector

Range

All-time high

$28.18B
NVS quarterly long term debt is currently -17.58% below its historical high of $28.18 billion

3-year low

$18.72B
NVS quarterly long term debt is currently +24.08% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
NVS previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 17, 2025
NVS next earnings announcement is scheduled for Jul 17, 2025

OtherNVSbalance sheet metrics

Quarterly Total Debt

$31.27B
NVS quarterly total debt is $31.27 billion

quarterly short term debt

$8.04B
NVS quarterly short term debt is $8.04 billion

quarterly total liabilities

$61.49B
NVS quarterly total liabilities is $61.49 billion

quarterly total assets

$99.94B
NVS quarterly total assets is $99.94 billion

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

NVS Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.5%+24.1%
3 y3 years-6.5%-4.7%
5 y5 years+4.0%-8.9%

NVS Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.5%+14.5%-8.4%+24.1%
5 y5-year-18.0%+14.5%-17.6%+24.1%
alltimeall time-18.0%+3396.0%-17.6%+3575.2%

NVS Long term debt History

DateAnnualQuarterly
Mar 2025
-
$23.23B(+1.3%)
Dec 2024
$22.93B(+14.5%)
$22.93B(-9.5%)
Sep 2024
-
$25.35B(+19.4%)
Jun 2024
-
$21.22B(+13.4%)
Mar 2024
-
$18.72B(-6.6%)
Dec 2023
$20.03B(-8.0%)
$20.03B(+2.6%)
Sep 2023
-
$19.52B(-1.4%)
Jun 2023
-
$19.80B(-9.9%)
Mar 2023
-
$21.98B(+0.9%)
Dec 2022
$21.78B(-11.2%)
$21.78B(+2.6%)
Sep 2022
-
$21.23B(-10.7%)
Jun 2022
-
$23.78B(-2.4%)
Mar 2022
-
$24.37B(-0.6%)
Dec 2021
$24.52B(-12.3%)
$24.52B(-0.8%)
Sep 2021
-
$24.71B(-6.7%)
Jun 2021
-
$26.49B(-3.3%)
Mar 2021
-
$27.40B(-2.1%)
Dec 2020
$27.98B(+26.8%)
$27.98B(-0.7%)
Sep 2020
-
$28.18B(+9.9%)
Jun 2020
-
$25.65B(+0.6%)
Mar 2020
-
$25.49B(+15.6%)
Dec 2019
$22.06B(-1.8%)
$22.06B(+1.0%)
Sep 2019
-
$21.83B(-1.3%)
Jun 2019
-
$22.12B(-3.4%)
Mar 2019
-
$22.89B(+1.9%)
Dec 2018
$22.47B(-3.2%)
$22.47B(-0.6%)
Sep 2018
-
$22.61B(-0.7%)
Jun 2018
-
$22.76B(-1.9%)
Mar 2018
-
$23.20B(-0.1%)
Dec 2017
$23.22B(+29.8%)
$23.22B(+0.3%)
Sep 2017
-
$23.16B(+0.7%)
Jun 2017
-
$23.00B(+0.3%)
Mar 2017
-
$22.93B(+28.1%)
Dec 2016
$17.90B(+9.6%)
$17.90B(-2.0%)
Sep 2016
-
$18.26B(+12.2%)
Jun 2016
-
$16.28B(-1.1%)
Mar 2016
-
$16.46B(+0.8%)
Dec 2015
$16.33B(+18.3%)
$16.33B(+21.7%)
Sep 2015
-
$13.41B(+0.8%)
Jun 2015
-
$13.30B(-10.3%)
Mar 2015
-
$14.83B(+7.5%)
Dec 2014
$13.80B(+22.7%)
$13.80B(+8.9%)
Sep 2014
-
$12.67B(-1.6%)
Jun 2014
-
$12.87B(-15.3%)
Mar 2014
-
$15.20B(+35.2%)
Dec 2013
$11.24B(-18.4%)
$11.24B(+1.1%)
Sep 2013
-
$11.12B(-4.3%)
Jun 2013
-
$11.62B(+0.0%)
Mar 2013
-
$11.61B(-15.8%)
DateAnnualQuarterly
Dec 2012
$13.78B(-0.5%)
$13.78B(-12.9%)
Sep 2012
-
$15.82B(+15.0%)
Jun 2012
-
$13.75B(-1.0%)
Mar 2012
-
$13.90B(+0.3%)
Dec 2011
$13.86B(-3.5%)
$13.86B(+0.9%)
Sep 2011
-
$13.74B(-1.3%)
Jun 2011
-
$13.92B(-4.2%)
Mar 2011
-
$14.53B(+1.2%)
Dec 2010
$14.36B(+65.5%)
$14.36B(+0.2%)
Sep 2010
-
$14.33B(+8.3%)
Jun 2010
-
$13.23B(-1.6%)
Mar 2010
-
$13.45B(+55.0%)
Dec 2009
$8.68B(+298.3%)
$8.68B(-0.4%)
Sep 2009
-
$8.71B(-5.3%)
Jun 2009
-
$9.20B(+31.8%)
Mar 2009
-
$6.98B(+220.4%)
Dec 2008
$2.18B(+221.7%)
$2.18B(+5.6%)
Sep 2008
-
$2.06B(-5.0%)
Jun 2008
-
$2.17B(+190.4%)
Mar 2008
-
$748.00M(+10.5%)
Dec 2007
$677.00M(+3.2%)
$677.00M(+1.5%)
Sep 2007
-
$667.00M(+5.5%)
Jun 2007
-
$632.00M(-4.4%)
Mar 2007
-
$661.00M(+0.8%)
Dec 2006
$656.00M(-50.3%)
$656.00M(-66.6%)
Sep 2006
-
$1.96B(+21.4%)
Jun 2006
-
$1.62B(+20.3%)
Mar 2006
-
$1.34B(+1.9%)
Dec 2005
$1.32B(-51.8%)
$1.32B(-45.8%)
Sep 2005
-
$2.44B(-2.3%)
Jun 2005
-
$2.49B(-3.8%)
Mar 2005
-
$2.59B(-5.3%)
Dec 2004
$2.74B(-14.3%)
$2.74B(-6.1%)
Sep 2004
-
$2.92B(-6.1%)
Jun 2004
-
$3.10B(-1.3%)
Mar 2004
-
$3.15B(-1.4%)
Dec 2003
$3.19B(+16.9%)
$3.19B(+4.9%)
Sep 2003
-
$3.04B(+0.7%)
Jun 2003
-
$3.02B(+4.3%)
Mar 2003
-
$2.90B(+6.2%)
Dec 2002
$2.73B(+81.4%)
$2.73B(+72.2%)
Sep 2002
-
$1.58B(-0.6%)
Jun 2002
-
$1.59B(+6.1%)
Dec 2001
$1.50B(+6.3%)
$1.50B(+9.1%)
Jun 2001
-
$1.38B(-2.6%)
Dec 2000
$1.42B(-7.8%)
$1.42B(-0.3%)
Jun 2000
-
$1.42B
Dec 1999
$1.53B(-25.6%)
-
Dec 1998
$2.06B
-

FAQ

  • What is Novartis AG annual long term debt?
  • What is the all time high annual long term debt for Novartis AG?
  • What is Novartis AG annual long term debt year-on-year change?
  • What is Novartis AG quarterly long term debt?
  • What is the all time high quarterly long term debt for Novartis AG?
  • What is Novartis AG quarterly long term debt year-on-year change?

What is Novartis AG annual long term debt?

The current annual long term debt of NVS is $22.93B

What is the all time high annual long term debt for Novartis AG?

Novartis AG all-time high annual long term debt is $27.98B

What is Novartis AG annual long term debt year-on-year change?

Over the past year, NVS annual long term debt has changed by +$2.90B (+14.48%)

What is Novartis AG quarterly long term debt?

The current quarterly long term debt of NVS is $23.23B

What is the all time high quarterly long term debt for Novartis AG?

Novartis AG all-time high quarterly long term debt is $28.18B

What is Novartis AG quarterly long term debt year-on-year change?

Over the past year, NVS quarterly long term debt has changed by +$4.51B (+24.08%)
On this page